BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aydin B, Arga KY, Karadag AS. Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects. Clin Cosmet Investig Dermatol 2020;13:611-25. [PMID: 32922059 DOI: 10.2147/CCID.S227896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Aydin B, Caliskan A, Arga KY. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies. EPMA J 2021;12:383-401. [PMID: 34567287 DOI: 10.1007/s13167-021-00246-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yamamoto Y, Kanayama N, Nakayama Y, Matsushima N. Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease. JPM 2022;12:444. [DOI: 10.3390/jpm12030444] [Reference Citation Analysis]
3 Rodríguez-fernández K, Mangas-sanjuán V, Merino-sanjuán M, Martorell-calatayud A, Mateu-puchades A, Climente-martí M, Gras-colomer E. Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis. Pharmaceutics 2022;14:654. [DOI: 10.3390/pharmaceutics14030654] [Reference Citation Analysis]
4 Wang H, Chen W, He J, Xu W, Liu J. Network analysis of potential risk genes for psoriasis. Hereditas 2021;158:21. [PMID: 34134787 DOI: 10.1186/s41065-021-00186-w] [Reference Citation Analysis]